Chance favours the prepared mind and it was a fortunate circumstance that the Henles were studying the Epstein-Barr (EB) virus (Epstein, 1970) when one of their technicians, whose serum was being used as a negative control, fell ill with typical infectious mononucleosis. During this illness, she developed not only heterophile antibodies but also fluorescent antibodies to the EB virus (Henle, Henle, and Diehl, 1968) . In another example of forethought, sera had been taken at intervals over the years from university students. Examination of these confirmed the association between the development of infectious mononucleosis and the acquisition ofantibodies to the EB virus (Evans, Niederman, and McCollum, 1968) . Subsequent studies (Niederman, Evans, Subrahmanyan, and McCollum, 1970; Sawyer, Evans, Niederman, and McCollum, 1971 (Klemola and Kaariiiinen, 1965; Lamb and Stern, 1966) but is uncommonly associated with EB virus infection (Klemola, von Essen, Henle, and Henle, 1970) .
The transmission of EB virus in man has been observed on several occasions. Grace, Blakeslee, and Jones (1969) inoculated serologically negative volunteers with cell extracts which contained EB virus: infectious mononucleosis developed in these individuals and they acquired EB virus antibodies. Accidental infection following perfusion with presumably infected blood has been described (Gerber, Walsh, Rosenblum, and Purcell, 1969) but Stevens and Pry (1971) considered this to be a rare event. Kapsenberg, Langenhuysen, Nieweg, and Deiss (1970) observed clinical infectious mononucleosis in a girl of 17 which followed a blood transfusion; she developed high levels of antibody to cytomegalovirus and also to EB virus. Spread of EB virus infection, with or without overt illness, has been detected in family and social contacts of children and young adults with infectious mononucleosis (Wahren, Lantorp, Sterner, and Espmark, 1970; Joncas and Mitnyan, 1970) ; the latter authors remarked upon the apparent low infectivity of this virus. To date, there have been no reports of the production of infectious mononucleosis in animals following the administration of EB virus, although Landon and Malan (1971) observed the decline of (probably) maternal antibodies in three species of macaque monkeys kept in captivity and tested over a period of months. Similarly, Gerber and Rosenblum (1968) have found EB virus antibodies in rhesus monkeys.
Although infectious mononucleosis is commonly associated with EB virus infection, there is much evidence that many infections must be asymptomatic or nearly so. Thus, Lehane (1970) in a prospective study of a military population, demonstrated a ratio of 1:10 in apparent to inapparent cases of infectious mononucleosis associated with EB virus serological conversion. In our own medical students and nurses, tested on entry for antibodies to rubella and to EB viruses, we found a close relationship between a history of past illness and the presence of antibodies to these viruses (Table I) (Henle, Henle, and Diehl, 1968; Pereira, Blake, and Macrae, 1969;  University Health Physicians and P.H.L.S. Laboratories Joint Investigation, 1971) for whilst antibodies appear to be acquired throughout childhood, the peak incidence of clinical infectious mononucleosis is not found until early adult life (Newell, 1957) .
The evidence thus indicates that infectious mononucleosis with a positive Paul-Bunnell test is often associated with EB virus infection but most infections with this virus are asymptomatic. Although generally accepted that the relationship is a fairly straightforward one, sceptics such as Glade, Hirschhorn, and Douglas (1969) consider that the antibody responses represent non-specific reactions to a variety of stimuli by a virus which is a harmless symbiont. Stevens, Pry, and Manaker (1970) . Knowledge of EB virus replication is now rather fuller and has disclosed a range of antigens which arise during this process. These antigens and the antibodies which may be produced against them may be detected in a variety of ways.
Antibodies to the EB Virus
The indirect fluorescent antibody test, using cells fixed in acetone , was the first method for detecting EB virus antibodies to be described and is usually the one which is implied when no other indication is given. These antibodies are directed towards the virus capsid (Zur Hausen, Henle, Hummeler, Diehl, and Henle, 1967; Epstein and Achong, 1968; Henle, Henle, Zajac, Pearson, Waubke, and Scriba, 1970) and are now termed viral capsid antigen (VCA) antibodies. This antigen develops late during virus replication and, as it is 3 associated with the virus particle, is not detectable in cell lines which are substantially 'virus-free' (as determined by electron microscopy), such as the Raji cell line or probably the RM cell line which we derived from a patient with infectious mononucleosis. During infectious mononucleosis, VCA antibodies develop rapidly and may be present shortly before the onset of frank illness. As they are present in over half of the age group in which infectious mononucleosis is commonly observed, their presence or absence is of little use in the diagnosis of this disease unless, of course, sera taken before the onset of illness are available. Viral capsid antigen antibodies decline gradually (Niederman et al, 1970) but may show considerable fluctuations (Sohier, 1970 Burchenal, 1967) . The membrane antigen is associated with the virus capsid but differs from the VCA antigen and is probably an early product of virus synthesis, as its formation is not inhibited by cytosine arabinoside or IUDR, whereas puromycin inhibits it completely (Gergely, Klein, and Ernberg, 1971) . It can be detected in cultured cells derived from patients with infectious mononucleosis (Klein, Pearson, Henle, Henle, Diehl, and Niederman, 1968) Pope, Home, and Scott, 1968; Dunkel and Ziegel, 1970) , a further antigen, the early antigen (EA), was detected (Henle, Henle, Ho, Burtin, Cachin, Clifford, de Schryver, de The, Diehl, and Klein, 1970; Hinuma, Sairenji, and Ohta-Hatano, 1971 ). This antigen is another early product of viral replication and is independent of viral DNA synthesis (Gergely et al, 1971) . As in the case of the cell membrane antigens it has some resemblance to antigens observed in cell cultures of tumours induced experimentally by oncogenic DNA viruses (Rapp, Butel, Feldman, Kitahara, and Melnick, 1965; Rapp, 1968 (Shigeta, Minowada, and Moore, 1971) .
We have been studying antibodies to a soluble complementfixing antigen prepared from virus-containing EB3 cells by the method of Armstrong, Henle, and Henle (1966) . A similar antigen prepared from the apparently 'virus-free' RM cell line reacted in the same way with test sera and it is thus possible that our antigen resembles the soluble antigen of .
Over half (64%) of medical students and nurses born in Europe or in North America possessed antibodies; almost all (95 %) of those born in tropical areas had similar evidence of previous infection (Table II Table III Relation of EB complement-fixing antibodies to past history of infectious mononucleosis in medical students and nurses admitted to hospital with infectious mononucleosis, compared with 88 patients admitted to the same hospital with other conditions, there was a significant association between low levels of complement-fixing antibodies and active infectious mononucleosis (Table IV) . These patients slowly developed antibodies and, when tested some months later, almost all had acquired high levels (Table V) Unlike the VCA antibodies, soluble complementfixing antibodies to the EB virus develop slowly after the onset of illness and there is some evidence (Sutton, Almond, Marston, and Emond, 1971 ) that the combined use of these tests could form the basis for a differential test for recent or remote infection (Table VI) (Old, Boyse, Oettgen, De Harven, Geering, Williamson, and Clifford, 1966; Fink and Cowles, 1968; Stevens, Pry, and Blackham, 1970 (Oettgen, Aoki, Geering, Boyse, and Old, 1967) and the precipitating antigens are probably associated with EB virus particle . (1970) observed that antibodies to early antigens were rarely seen in sera other than those from patients with Burkitt's tumour, nasopharyngeal carcinoma, or infectious mononucleosis, and Pearson, Henle, and Henle (1971) noted that three lymphoblastoid cell lines responded in differing ways to experimental infection with EB virus, one line producing early antigen but not membrane or viral capsid antigens, another responding with high titres of viral capsid and membrane antigens. Such differences might well influence the expression of virus infection, acting (by analogy with herpes simplex virus) via the glycoprotein specified by the virus (Spear, Keller, and Roizman, 1970) , which is detectable by an altered immunological specificity on the cell membrane (Roizman and Spring, 1967) and which isaccompanied by alterations in the 'social behaviour' of the cell (Roizman, 1971) . Whether these differences are due to intratypic variation in the virus or to host variation (possibly genetic in nature) is not known; in the system described by Pearson et al (1971) , host variation is clearly important.
These observations chime well with our present knowledge linking the EB virus with Burkitt's lymphoma and with nasopharyngeal carcinoma, and the connexion with infectious mononucleosis is thought-provoking. Clinical infectious mononucleosis bears no patent relationship with malignant disease although, rarely, it may be followed by Burkitt's tumour (Cohen, Hirshaut, Stevens, Hull, Davis, and Carbone, 1970) or by Hodgkin's disease (English, 1970 (Wollheim and Williams, 1966, Holborow, Asherson, Johnson, Barnes, and Carmichael, 1963; Carter, 1966) , as has anti 'i' (Wollheim and Williams, 1966) , rheumatoid factor (Dresner and Trombly, 1959; Holborow et al, 1963) , and cryoproteins (Kaplan, 1968) . In general, these abnormal antibodies are seen infrequently and, in our series, we have observed a positive latex test in one of 79 patients with infectious mononucleosis, many of whom were tested at various stages during their illness.
There has been at least one report of transient depression of cell-mediated hypersensitivity, as assessed by the tuberculin reaction. Jones (1970) observed that six of 13 patients with acute infectious mononucleosis exhibited negative reactions to tuberculin (100 TU) early in their illnesses which reverted to positive in convalescence. Of our own patients, De Coutinho (personal communication) has observed two who were given BCG at unspecified times before the illness (possibly in childhood) and were tuberculin negative during the acute phase of infectious mononucleosis, reverting to a positive state during convalescence.
Conclusions
There is good evidence that much of the population is infected with the EB virus in childhood or later. Most infections are, apparently, asymptomatic but, in some, infection with the EB virus is associated with 'Paul-Bunnell positive' (but not 'Paul-Bunnell negative') infectious mononucleosis. Following EB virus infection, whether accompanied by overt illness or not, a variety of specific antibodies develop. These are directed against the EB virus particle and against antigens specified during early stages of viral synthesis; the latter resemble antigens which are formed during experimental infections with oncogenic DNA viruses.
Infectious mononucleosis, unlike the other conditions for whose aetiology the EB virus is a candidate, is not a malignant condition. Nevertheless, the suspicion of oncogenicity attached to the EB virus and its wide prevalence in the community make closer observation of its host-virus reactions an important object for further investigations. Such work as has been done suggests that the EB virus may be responsible for abnormal humoral and cellular
